Skip header and navigation

32 records – page 1 of 2.

5-Aminosalicylate (5-ASA)

http://libcat.nshealth.ca/permalink/chpams35397
Nova Scotia Health Authority. Central Zone. Gastroenterology. Halifax, NS: Nova Scotia Health Authority , 2016.
Pamphlet Number
1483
Available Online
View Pamphlet
5-aminosalicylate (5-ASA) is a type of drug often used to treat inflammatory bowel disease (IBD). This type of drug is good at controlling active ulcerative colitis or Crohn’s colitis as well as keeping ulcerative colitis in remission. Topics include: what 5-ASA type drugs do, which 5-ASA you should take, continuing to take the drug, talking to your doctor, what other medication you can take, and when to expect to see improvement. The pamphlet also describes common and rare side effects.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Central Zone. Gastroenterology
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2016
Format
Pamphlet
Language
English
Physical Description
1 electronic document (6 p.) : digital, PDF file
Subjects (MeSH)
Colitis - drug therapy
Crohn Disease - drug therapy
Inflammatory Bowel Diseases - drug therapy
Other Subjects
Colitis
Crohn's disease
Inflammatory bowel diseases
Abstract
5-aminosalicylate (5-ASA) is a type of drug often used to treat inflammatory bowel disease (IBD). This type of drug is good at controlling active ulcerative colitis or Crohn’s colitis as well as keeping ulcerative colitis in remission. Topics include: what 5-ASA type drugs do, which 5-ASA you should take, continuing to take the drug, talking to your doctor, what other medication you can take, and when to expect to see improvement. The pamphlet also describes common and rare side effects.
Responsibility
Prepared by: Jennifer Stewart, RN; Gastroenterology
Prepared by: Kaleigh MacIsaac, B.ScPharm; Gastroenterology
Revised by: Alison Harding, B.Sc.
Revised by: Phyllis Durning, RN
Pamphlet Number
1483

Adalimumab (Humira®) therapy

http://libcat.nshealth.ca/permalink/chpams35127
Nova Scotia Health Authority. Central Zone. Gastroenterology. Halifax, NS: Nova Scotia Health Authority , 2016.
Pamphlet Number
1207
Available Online
View Pamphlet
Your healthcare provider feels that treatment with adalimumab may be helpful in managing your inflammatory bowel disease (IBD). This pamphlet describes what adalimumab is and some important aspects of therapy with this medication. Precautions and possible side effects are listed.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Central Zone. Gastroenterology
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2016
Format
Pamphlet
Language
English
Physical Description
1 electronic document (9 p.) : digital, PDF file
Subjects (MeSH)
Adalimumab
Inflammatory Bowel Diseases - drug therapy
Other Subjects
Inflammatory bowel diseases
Specialty
Medications
Abstract
Your healthcare provider feels that treatment with adalimumab may be helpful in managing your inflammatory bowel disease (IBD). This pamphlet describes what adalimumab is and some important aspects of therapy with this medication. Precautions and possible side effects are listed.
Responsibility
Prepared by: Division of Gastroenterology
Pamphlet Number
1207

Alimentation et maladies inflammatoires de l'intestin

http://libcat.nshealth.ca/permalink/provcat4700
Fondation canadienne des maladies inflammatoires de l'intestin. CCFC , 1993.
Call Number
616 .344 AL45
Location
IWK Family Resource Library
Call Number
616 .344 AL45
Corporate Author
Crohn's and Colitis Foundation of Canada
Responsibility
Fondation canadienne des maladies inflammatoires de l'intestin
Place of Publication
Toronto, ON
Publisher
CCFC
Date Published
1993
Physical Description
16 p.
Subjects (LCSH)
Enteritis, Regional
Inflammatory bowel diseases
Ulcerative colitis
Other Subjects
Entérite régionale
Maladie de Crohn
Language
French
Location
IWK Family Resource Library
Copies
2

The Angry gut : coping with colitis and Crohn's disease

http://libcat.nshealth.ca/permalink/provcat4652
W. Grant Thompson. Plenum Press , c1993.
Call Number
616 .344 T379 1993
Location
IWK Family Resource Library
Call Number
616 .344 T379 1993
Author
Thompson, W. Grant
Responsibility
W. Grant Thompson
Place of Publication
New York
Publisher
Plenum Press
Date Published
c1993
Physical Description
350 p.
Subjects (MeSH)
Colitis, Ulcerative
Crohn's disease
Subjects (LCSH)
Enteritis, Regional
Inflammatory bowel diseases
Ulcerative colitis
Location
IWK Family Resource Library

Aspects psychologiques des maladies inflammatoires de l'intestin

http://libcat.nshealth.ca/permalink/provcat4699
Fondation canadienne des maladies inflammatoires de l'intestin. CCFC , [1993?].
Call Number
616 .344 As63
Location
IWK Family Resource Library
Call Number
616 .344 As63
Corporate Author
Crohn's and Colitis Foundation of Canada
Responsibility
Fondation canadienne des maladies inflammatoires de l'intestin
Place of Publication
Toronto, ON
Publisher
CCFC
Date Published
[1993?]
Physical Description
10 p.
Subjects (LCSH)
Enteritis, Regional
Inflammatory bowel diseases
Ulcerative colitis
Other Subjects
Entérite régionale
Maladie de Crohn
Language
French
Location
IWK Family Resource Library
Copies
2

Colitis-Associated Cancer

http://libcat.nshealth.ca/permalink/provcat40391
Masato Kusunoki, editor. (1st ed.) Springer Japan , c2016.
Available Online
View e-Book
Location
Online
As the number of patients with colitis-associated cancer (CAC) is on the increase, the purpose of this book is to review the latest topics concerning management of the disease. In recent years, the diagnostic power of endoscopy and molecular pathology has also grown tremendously, as a result of which they now have a far greater influence on the treatment of CAC. At the moment, appropriate monitoring programs for ulcerative colitis and Crohn's disease remain uncertain. At the same time, the late…
Available Online
View e-Book
Other Authors
Kusunoki, Masato
Responsibility
Masato Kusunoki, editor
Edition
1st ed.
Place of Publication
Tokyo
Publisher
Springer Japan
Date Published
c2016
Physical Description
1 online resource (viii, 150 p. : 21 illus., 15 illus. in color)
ISBN
9784431555216 (print ed.)
9784431555223
Subjects (MeSH)
Colitis - complications
Colonic Neoplasms - etiology
Inflammatory bowel diseases
Other Subjects
; Medicine & Public Health
Cancer Research
Gene Function
Surgery
Surgical Oncology
Abstract
As the number of patients with colitis-associated cancer (CAC) is on the increase, the purpose of this book is to review the latest topics concerning management of the disease. In recent years, the diagnostic power of endoscopy and molecular pathology has also grown tremendously, as a result of which they now have a far greater influence on the treatment of CAC. At the moment, appropriate monitoring programs for ulcerative colitis and Crohn's disease remain uncertain. At the same time, the latest findings on DNA methylation and microRNAs hold the promise of making revolutionary changes in these areas. Moreover, recent drug advances in the treatment of inflammatory bowel diseases have changed surgical indications. On the other hand, the indication of mucosectomy on colorectal cancer in ulcerative colitis and prophylactic abdominoperineal resection for Crohn's disease remain controversial. This book provides the latest information on the remaining issues of CAC from the point of view of expert surgeons.
Contents
1. Colitis-Associated Cancer: Overview -- Part I. Clinical Features -- 2. Incidence and Risk Factors -- 3. Prevention and Prognosis -- Part II. Diagnosis -- 4. Cancer Surveillance of Patients with Long-Standing Inflammatory Bowel Disease -- 5. Molecular Alterations in Inflammatory Colonic Carcinogenesis and Markers for Detecting Colitis-Associated Cancer -- Part III. Surgical Treatment -- 6. Surgical Treatment for Ulcerative Colitis-Associated Cancer or Dysplasia -- 7. Surgical Treatment for Colorectal Cancer in Crohn's Disease.
Format
e-Book
Location
Online
thumbnail

Colitiscope : living with crohn's disease and ulcerative colitis

http://libcat.nshealth.ca/permalink/provcat8309
Andrew Tubesing. Pfeifer-Hamilton Publishers , 2009.
Call Number
616 .344 T79 2009
Location
IWK Family Resource Library
Insights many of the struggles common to IBD sufferers, while discussing symptoms, treatments, medications, and procedures.
Call Number
616 .344 T79 2009
Author
Tubesing, Andrew
Responsibility
Andrew Tubesing
Place of Publication
Alburquerque, New Mexico
Publisher
Pfeifer-Hamilton Publishers
Date Published
2009
Physical Description
ix, 179 p.
Subjects (LCSH)
Colitis
Crohn's disease
Inflammatory bowel diseases
Abstract
Insights many of the struggles common to IBD sufferers, while discussing symptoms, treatments, medications, and procedures.
Location
IWK Family Resource Library
Copies
1

Corticosteriod therapy in inflammatory bowel disease

http://libcat.nshealth.ca/permalink/chpams35480
Capital Health (N.S.). Gastroenterology. Halifax, NS: Capital Health , 2014.
Pamphlet Number
1546
Available Online
View Pamphlet
Corticosteroids (kor-ti-koh-STER-oids) are strong inhibitors of inflammation. This pamphlet explains what corticosteriods do, how they work, when they are used, and how they are given. What to expect after treatment, cost, precautions, side effects, and a list of symptoms that require you to contact your doctor are provided. ; This pamphlet replaced pamphlet 1139, Prednisone Therapy.
Available Online
View Pamphlet
Corporate Author
Capital Health (N.S.). Gastroenterology
Alternate Title
Corticosteriod therapy in IBD
Place of Publication
Halifax, NS
Publisher
Capital Health
Date of Publication
2014
Format
Pamphlet
Language
English
Physical Description
1 electronic document (8 p.) : digital, PDF file
Subjects (MeSH)
Inflammatory Bowel Diseases - drug therapy
Prednisone
Other Subjects
Inflammatory bowel diseases
Prednisone
Specialty
Gastroenterology
Medications
Abstract
Corticosteroids (kor-ti-koh-STER-oids) are strong inhibitors of inflammation. This pamphlet explains what corticosteriods do, how they work, when they are used, and how they are given. What to expect after treatment, cost, precautions, side effects, and a list of symptoms that require you to contact your doctor are provided.
This pamphlet replaced pamphlet 1139, Prednisone Therapy.
Notes
This pamphlet replaced pamphlet 1139, Prednisone Therapy.
Responsibility
Prepared by: Gastroenterology
Pamphlet Number
1546

Crohn's and colitis : understanding and managing IBD

http://libcat.nshealth.ca/permalink/provcat7148
A. Hillary Steinhart. Robert Rose Inc. , 2006.
Call Number
616 .344 St35 2006
Location
IWK Family Resource Library
Provides current and concise information on the possible underlying causes, clinicalm features, and effective treatments of Crohn's disease and ulcerative colitis.
Call Number
616 .344 St35 2006
Author
Steinhart, Hillary A.
Responsibility
A. Hillary Steinhart
Place of Publication
Toronto
Publisher
Robert Rose Inc.
Date Published
2006
Physical Description
224 p.
Subjects (LCSH)
Crohn's disease
Inflammatory bowel diseases
Ulcerative colitis
Abstract
Provides current and concise information on the possible underlying causes, clinicalm features, and effective treatments of Crohn's disease and ulcerative colitis.
Location
IWK Family Resource Library
Copies
2

Crohn's disease & ulcerative colitis

http://libcat.nshealth.ca/permalink/provcat4976
Fred Saibil. Key Porter Books , c1996.
Call Number
616 .344 SA21 1996
Location
IWK Family Resource Library
Call Number
616 .344 SA21 1996
Author
Saibil, Frederic G.
Responsibility
Fred Saibil
Place of Publication
Toronto, ON
Publisher
Key Porter Books
Date Published
c1996
Physical Description
216 p.
Subjects (LCSH)
Enteritis, Regional
Inflammatory bowel diseases
Ulcerative colitis
Location
IWK Family Resource Library
Copies
2

Dealing with digestive disorders

http://libcat.nshealth.ca/permalink/provcat6535
Gale Group. Gale Group , 2004.
Call Number
616 .344 D342 2004
Location
IWK Family Resource Library
Information on different digestive disorders, their causes, and treatments.
Call Number
616 .344 D342 2004
Responsibility
Gale Group
Publisher
Gale Group
Date Published
2004
Physical Description
11 p.
Subjects (LCSH)
Colitis
Inflammatory bowel diseases
Abstract
Information on different digestive disorders, their causes, and treatments.
Location
IWK Family Resource Library
Copies
1

Frequently asked questions about ileitis and colitis

http://libcat.nshealth.ca/permalink/provcat4335
Crohn's and Colitis Foundation of Canada. CCFC , 1993.
Call Number
616 .344 F89 1993
Location
IWK Family Resource Library
Call Number
616 .344 F89 1993
Corporate Author
Crohn's and Colitis Foundation of Canada
Responsibility
Crohn's and Colitis Foundation of Canada
Place of Publication
Toronto, ON
Publisher
CCFC
Date Published
1993
Physical Description
[9] p.
Subjects (MeSH)
Crohn's disease
Subjects (LCSH)
Enteritis, Regional
Ileum - Diseases
Inflammatory bowel diseases
Ulcerative colitis
Location
IWK Family Resource Library
Copies
2

Golimumab (Simponi®) therapy

http://libcat.nshealth.ca/permalink/chpams35651
Nova Scotia Health Authority. Central Zone. Division of Gastroenterology. Halifax, NS: Nova Scotia Health Authority , 2016.
Pamphlet Number
1641
Available Online
View Pamphlet
Your healthcare provider feels that treatment with golimumab may be helpful in managing your inflammatory bowel disease (IBD). This pamphlet describes what golimumab is and some important aspects of therapy with this medication. Precautions and possible side effects are listed.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Central Zone. Division of Gastroenterology
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2016
Format
Pamphlet
Language
English
Physical Description
1 electronic document (9 p.) : digital, PDF file
Subjects (MeSH)
Golimumab
Inflammatory Bowel Diseases - drug therapy
Other Subjects
Inflammatory bowel diseases
Specialty
Medications
Abstract
Your healthcare provider feels that treatment with golimumab may be helpful in managing your inflammatory bowel disease (IBD). This pamphlet describes what golimumab is and some important aspects of therapy with this medication. Precautions and possible side effects are listed.
Responsibility
Prepared by: Division of Gastroenterology
Pamphlet Number
1641

Inflammatory Bowel Disease : A Point of Care Clinical Guide

http://libcat.nshealth.ca/permalink/provcat39181
Daniel J. Stein, Reza Shaker, editors. Springer , c2015.
Available Online
View e-Book
Location
Online
This volume provides a unique point-of-care reference for clinicians who care for Inflammatory Bowel Disease patients. Busy clinicians need the best evidence based answers to patient questions at their fingertips at the time questions present themselves. Each chapter is based on responses to common IBD patient questions from IBD experts who answer these questions every day. Through these questions this book guides clinicians through the complicated management of IBD; including disease onset and…
Available Online
View e-Book
Other Authors
Shaker, Reza
Stein, Daniel J
Responsibility
Daniel J. Stein, Reza Shaker, editors
Place of Publication
Cham
Publisher
Springer
Date Published
c2015
Physical Description
1 online resource (xvii, 237 p. : 4 illus., 3 illus. in color)
ISBN
9783319140711 (print ed.)
9783319140728
Subjects (MeSH)
Evidence-based medicine - methods
Inflammatory bowel diseases
Physician-Patient Relations
Other Subjects
Gastroenterology
Hepatology
Medicine & Public Health
Abstract
This volume provides a unique point-of-care reference for clinicians who care for Inflammatory Bowel Disease patients. Busy clinicians need the best evidence based answers to patient questions at their fingertips at the time questions present themselves. Each chapter is based on responses to common IBD patient questions from IBD experts who answer these questions every day. Through these questions this book guides clinicians through the complicated management of IBD; including disease onset and natural history, therapy initiation, medications complications, therapeutic monitoring, surgery and accurate disease monitoring. Lastly, the book addresses special situations, such as alternative therapies, pregnancy, and fertility. Written by experts in the field, Inflammatory Bowel Disease: A Point of Care Clinical Guide is a valuable reference for gastroenterologists, gastroenterology fellows, mid-level providers and any clinician involved in the care of IBD patients.
Contents
[publisher supplied] 1. Why did this happen to me?: Epidemiology, Genetics, Environment, and Etiology of IBD -- 2. So what is Crohn's disease and Ulcerative colitis?: Making the proper diagnosis, avoiding IBD mimickers, and identifying factors that distinguish CD from UC -- 3. What happens if I do nothing?: The natural history of IBD, treated and untreated -- 4. Proper staging and management of newly diagnosed Crohn's disease -- 5. Proper staging and management of newly diagnosed Ulcerative colitis -- 6. Monitoring for common side effects and adverse reactions of IBD medications -- 7. Healthcare maintenance in patients with IBD -- 8. Pregnancy and unique women's issues in IBD -- 9. Imaging and IBD -- 10. Perianal Crohn's disease -- 11. Surgical management of Crohn's disease -- 12. Management of severe/fulminant Ulcerative colitis -- 13. Surgical management of Ulcerative colitis -- 14. Post operative management of IBD patients -- 15. Pouchitis -- 16. Ostomies.
Format
e-Book
Location
Online
thumbnail

Inflammatory Bowel Disease : From Bench to Bedside

http://libcat.nshealth.ca/permalink/provcat40487
edited by Stephan R. Targan, Fergus Shanahan, Loren C. Karp. (2nd edition) Springer , c2003.
Available Online
View e-Book
Inflammatory Bowel Disease: From Bench to Bedside is a detailed and comprehensive story of the local and systemic pathophysiology of intestinal inflammation including management strategies. Research advances and current concepts of etiopathogenesis in the context of what is already known of the clinicopathologic features of these disorders are explored. This volume blends recent advances in the basic and clinical sciences as they relate to inflammatory bowel disease and emphasizes the effective…
Available Online
View e-Book
Other Authors
Karp, Loren C
Shanahan, Fergus
Targan, Stephan R
Responsibility
edited by Stephan R. Targan, Fergus Shanahan, Loren C. Karp
Edition
2nd edition
Place of Publication
New York
Publisher
Springer
Date Published
c2003
Physical Description
1 online resource (xvi, 903 p. : 98 illus., 9 illus. in color)
ISBN
9780387258072 (print ed.)
9780387258089
Subjects (MeSH)
Inflammatory bowel diseases
Other Subjects
; Medicine & Public Health
Gastroenterology
Internal Medicine
Medical Biochemistry
Abstract
Inflammatory Bowel Disease: From Bench to Bedside is a detailed and comprehensive story of the local and systemic pathophysiology of intestinal inflammation including management strategies. Research advances and current concepts of etiopathogenesis in the context of what is already known of the clinicopathologic features of these disorders are explored. This volume blends recent advances in the basic and clinical sciences as they relate to inflammatory bowel disease and emphasizes the effectiveness of a team approach of basic scientists and clinician investigators in this field.
Contents
Section 1. The laboratory bench -- 1. Introduction: Inflammatory bowel diseases: from bench to bedside -- 2. The changing faces of Crohn's disease and ulcerative colitis -- 3. Genetics of inflammatory bowel disease -- 4. Experimental mouse models of inflammatory bowel disease: new insights into pathogenic mechanisms -- 5. The normal intestinal mucosa: a state of 'controlled inflammation' -- 6. The lymphocyte-epithelial-bacterial interface -- 7. The mucosal inflammatory response. Cytokines and chemokines -- 8. Role of the microcirculation in chronic gut inflammation -- 9. Remission, relapse, intestinal healing and repair -- 10. Antibodies in the exploration of inflammatory bowel disease pathogenesis and disease stratification -- 11. Pathophysiology of inflammatory bowel disease: the effect of inflammation on intestinal function -- 12. Systemic consequences of intestinal inflammation -- Section II. The bedside -- 13. Understanding symptoms and signs in inflammatory bowel disease -- 14. Clinical course and complications of ulcerative colitis and ulcerative proctitis -- 15. Clinical features and complications of Crohn's disease -- 16. Mechanisms of systemic inflammation associated with intestinal injury -- 17. Pathology of inflammatory bowel diseases: a critical appraisal in diagnosis and management -- 18. An endoscopic and histologic perspective of diagnosis: when, where, and what to do -- 19. Radiologic (radiographic) and imaging features of ulcerative cohtis and Crohn's disease -- 20. New diagnostic approaches in inflammatory bowel disease -- 21. Differential diagnosis of colitis -- 22. 'Disease management' in chronic medical conditions -- 23. Pharmacoeconomics and inflammatory bowel disease -- 24. Measuring quality of life in inflammatory bowel disease -- 25. Clinical pharmacology in inflammatory bowel disease: optimizing current medical therapy -- 26. Multi-site therapeutic modalities for inflammatory bowel diseases - mechanisms of action -- 27. Targeted therapies for inflammatory bowel disease -- 28. Role of antibiotics and probiotics in the management of inflammatory bowel disease -- 29. Nutrition in inflammatory bowel disease -- 30. Medical management of ulcerative colitis -- 31. Surgical management of ulcerative colitis -- 32. Pouchitis: clinical characteristics and management -- 33. Medical therapy for Crohn's disease -- 34. Surgery for Crohn's disease -- 35. Postoperative prevention of recurrence of Crohn's disease -- 36. The molecular pathology of inflammatory bowel disease-associated neoplasia and preneoplasia -- 37. Dysplasia in inflammatory bowel disease: clinical pathology and current surveillance methods -- 38. Hepatobiliary disorders -- 39. Articular and ocular complications of inflammatory bowel disease -- 40. Cutaneous manifestations of inflammatory bowel disease -- 41. Fertility and pregnancy in inflammatory bowel disease -- 42. Special considerations in the diagnosis and management of inflammatory bowel disease in the pediatric age group -- 43. Microscopic colitis: collagenous and lymphocytic colitis -- 44. Colon ischemia -- 45. Diversion colitis -- 46. Pseudomembranous colitis and Clostridium difficile infection -- 47. Infectious colitis -- 48. Human immunodeficiency virus and inflammatory bowel disease -- 49. Bone metabolism and inflammatory bowel disease -- Section III. Back to the laboratory bench -- 50. Epilogue: Bench to bedside and back to bench.
Format
e-Book
thumbnail

Infliximab (Remicade) therapy

http://libcat.nshealth.ca/permalink/chpams34944
Nova Scotia Health Authority. Central Zone. Gastroenterology. Halifax, NS: Nova Scotia Health Authority , 2016.
Pamphlet Number
1140
Available Online
View Pamphlet
Your healthcare provider feels that treatment with infliximab may be helpful in managing your inflammatory bowel disease (IBD). This pamphlet describes what infliximab is and some important aspects of therapy with this medication. Precautions and possible side effects are listed.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Central Zone. Gastroenterology
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2016
Format
Pamphlet
Language
English
Physical Description
1 electronic document (9 p.) : digital, PDF file
Subjects (MeSH)
Inflammatory Bowel Diseases - drug therapy
Infliximab
Other Subjects
Inflammatory bowel diseases
Infliximab
Abstract
Your healthcare provider feels that treatment with infliximab may be helpful in managing your inflammatory bowel disease (IBD). This pamphlet describes what infliximab is and some important aspects of therapy with this medication. Precautions and possible side effects are listed.
Responsibility
Prepared by: Division of Gastroenterology
Pamphlet Number
1140

Information aux professeurs sur la maladie de Crohn et sur la colite ulcéreuse

http://libcat.nshealth.ca/permalink/provcat4698
Fondation canadienne des maladies inflammatoires de l'intestin. CCFC , [1993?].
Call Number
616 .344 In31
Location
IWK Family Resource Library
Call Number
616 .344 In31
Corporate Author
Crohn's and Colitis Foundation of Canada
Responsibility
Fondation canadienne des maladies inflammatoires de l'intestin
Place of Publication
Toronto, ON
Publisher
CCFC
Date Published
[1993?]
Physical Description
7 p.
Subjects (LCSH)
Enteritis, Regional
Inflammatory bowel diseases
Ulcerative colitis
Other Subjects
Entérite régionale
Maladie de Crohn
Language
French
Location
IWK Family Resource Library
Copies
2

Irritable bowel syndrome : frequently asked questions

http://libcat.nshealth.ca/permalink/provcat6536
Laura Zurawski and Anthony Lembo. , 2004.
Call Number
616 .344 z87 2004
Location
IWK Family Resource Library
Answers to the commonly asked questions about inflammatory bowel diseases.
Call Number
616 .344 z87 2004
Author
Lembo, Anthony
Zurawski, Laura
Responsibility
Laura Zurawski and Anthony Lembo
Date Published
2004
Physical Description
12 p.
Subjects (LCSH)
Colitis
Inflammatory bowel diseases
Abstract
Answers to the commonly asked questions about inflammatory bowel diseases.
Location
IWK Family Resource Library
Copies
1

Methotrexate therapy for inflammatory bowel disease (IBD)

http://libcat.nshealth.ca/permalink/chpams34942
Nova Scotia Health Authority (Central Zone). Gastroenterology. Halifax, NS: Nova Scotia Health Authority , 2015.
Pamphlet Number
1138
Available Online
View Pamphlet
This pamphlet provides information about taking Methotrexate to treat inflammatory bowel disease (IBD). The pamphlet describes what Methotrexate does, and how well it works. Lists of minor and serious side effects are included. The pamphlet explains who should not take Methotrexate, and precautions you will need to take while on the treatment. The pamphlet outlines instructions about injecting Methotrexate. These instructions include what to do beforehand, how to prepare and give the injection…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority (Central Zone). Gastroenterology
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2015
Format
Pamphlet
Language
English
Physical Description
1 electronic document (12 p.) : digital, PDF file
Subjects (MeSH)
Crohn's disease
Immunosuppressive Agents
Inflammatory Bowel Diseases
Methotrexate
Other Subjects
Crohn's disease
Immunosuppressive agents
Inflammatory bowel diseases
Methotrexate
Specialty
Gastroenterology
Abstract
This pamphlet provides information about taking Methotrexate to treat inflammatory bowel disease (IBD). The pamphlet describes what Methotrexate does, and how well it works. Lists of minor and serious side effects are included. The pamphlet explains who should not take Methotrexate, and precautions you will need to take while on the treatment. The pamphlet outlines instructions about injecting Methotrexate. These instructions include what to do beforehand, how to prepare and give the injection, where to inject the treatment, and what to do if you get Methotrexate on your skin, work area, or in your eye.
Responsibility
Updated by: Tim Mombourquette (GI Research Student) & Jennifer Stewart RNCCRP
Pamphlet Number
1138

More questions about Crohn's disease & ulcerative colitis

http://libcat.nshealth.ca/permalink/provcat4065
Canadian Foundation for Ileitis and Colitis. The Foundation , [1990?].
Call Number
616 .344 M813
Location
IWK Family Resource Library
Call Number
616 .344 M813
Corporate Author
Canadian Foundation for Ileitis and Colitis
Responsibility
Canadian Foundation for Ileitis and Colitis
Place of Publication
Toronto, ON
Publisher
The Foundation
Date Published
[1990?]
Physical Description
[18] p.
Subjects (MeSH)
Crohn's disease
Subjects (LCSH)
Enteritis, Regional
Inflammatory bowel diseases
Ulcerative colitis
Location
IWK Family Resource Library

32 records – page 1 of 2.

Revise Search

Narrow By